Estamos no ar no !
Saiba mais
Oric Pharmaceuticals
| Nome | Posição | Valor negociado |
Ações Variação |
Variação na participação |
|
|---|---|---|---|---|---|
1
Nextech Invest
Zurich,
Switzerland
| US$ 90,8 mi | – | – | – |
|
2
EcoR1 Capital
San Francisco,
California
| US$ 85,2 mi | – | – | – |
|
3
BlackRock
New York
| US$ 75,8 mi | +US$ 1,24 mi | +109.499 | +2% |
|
4
Viking Global Investors
Stamford,
Connecticut
| US$ 73,8 mi | -US$ 8,49 mi | -748.158 | -11% |
|
5
T. Rowe Price Associates
Baltimore,
Maryland
| US$ 68,3 mi | +US$ 23,8 mi | +2.092.661 | +64% |
|
6
SR One Capital Management
Wayne,
Pennsylvania
| US$ 58,5 mi | – | – | – |
|
7
Pfizer
New York
| US$ 57,7 mi | -US$ 6,77 mi | -595.943 | -11% |
|
8
Alkeon Capital Management
New York
| US$ 57,1 mi | – | – | – |
|
9
VR Adviser
New York
| US$ 54,7 mi | -US$ 15,4 mi | -1.356.465 | -24% |
|
10
NEA Management Company
Timonium,
Maryland
| US$ 52,2 mi | – | – | – |
|
11
State Street
Boston,
Massachusetts
| US$ 46,9 mi | -US$ 6,31 mi | -556.201 | -13% |
|
12
Vanguard Capital Management
Malvern,
Pennsylvania
| US$ 46,7 mi | +US$ 41,9 mi | +3.687.007 | Nova |
|
13
Column Group
San Francisco,
California
| US$ 44,9 mi | – | – | – |
|
|
SL
14
Siren LLC
Greenwich,
Connecticut
| US$ 38 mi | +US$ 22,6 mi | +1.990.617 | +198% |
|
15
OrbiMed
New York
| US$ 34,1 mi | -US$ 10,8 mi | -947.827 | -26% |
|
16
AIHC Capital Management
Central,
| US$ 31,2 mi | +US$ 27,9 mi | +2.459.551 | Nova |
|
17
Fidelity Investments
Boston,
Massachusetts
| US$ 30,8 mi | -US$ 509 mil | -44.842 | -2% |
|
18
Citadel Advisors
Miami,
Florida
| US$ 30,7 mi | -US$ 136 mil | -11.969 | -0,5% |
|
19
First Turn Management
Del Mar,
California
| US$ 25,6 mi | +US$ 79,2 mil | +6.977 | +0,3% |
|
20
Vivo Capital
Palo Alto,
California
| US$ 23,4 mi | -US$ 3,06 mi | -269.598 | -13% |
|
21
Geode Capital Management
Boston,
Massachusetts
| US$ 23,3 mi | +US$ 1 mi | +88.107 | +5% |
|
22
MPM BioImpact
Boston,
Massachusetts
| US$ 22,9 mi | +US$ 59,3 mil | +5.228 | +0,3% |
|
23
Paradigm Biocapital Advisors
New York
| US$ 21,6 mi | -US$ 7,95 mi | -700.000 | -29% |
|
24
Morgan Stanley
New York
| US$ 21,3 mi | +US$ 5,54 mi | +488.450 | +41% |
|
25
Goldman Sachs
New York
| US$ 18,7 mi | -US$ 5,26 mi | -463.573 | -24% |
|